Skip to main content
Clinical Trials/NCT05075668
NCT05075668
Completed
Not Applicable

Continuous Positive Airway Pressure Therapy Via Conventional CPAP Face Mask Versus High Flow Nasal Cannula in OSA Patients on the First Postoperative Night- a Pilot Randomised Study

Changi General Hospital1 site in 1 country40 target enrollmentSeptember 13, 2018
ConditionsOSA

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
OSA
Sponsor
Changi General Hospital
Enrollment
40
Locations
1
Primary Endpoint
Number of participants with documented desaturations (defined as >4% drop from baseline)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

High flow, humidified, temperature-regulated nasal insufflation is not a new concept. It is used widely in the treatment of hypoxaemic respiratory failure in critically ill patients, as an alternative to non-invasive positive ventilation via face or nasal mask. Recently, its use has been extended to the perioperative setting for pre-oxygenation and prolonging apnoeic time to desaturation. Both CPAP and high flow nasal cannula insufflation devices are licensed for use clinically in Singapore. We conduct this pilot study because its perioperative use in our adult OSA population is currently not well-defined.

Detailed Description

Continuous positive airway pressure (CPAP) therapy is the only treatment for obstructive sleep apnoea (OSA) shown to reduce its long-term adverse effects on the cardiovascular system. However, due to difficult patient-mask interface and discomfort, compliance rate amongst patients with OSA is low, and reported to be only between 20-50%. High flow, humidified, temperature-regulated nasal cannula insufflation (of air or oxygen) is a well-documented and safe treatment in intensive care, paediatrics and respiratory medicine for patients with hypoxaemic respiratory failure. Its use in adult patients with obstructive sleep apnoea, especially in the perioperative setting is not well studied. Our hospital has a ''fast-track'' protocol for OSA patients who require surgery. They are started on CPAP therapy 2 to 5 days prior to surgery and in the immediate post operative period (ie. perioperatively). If these patients are non-compliant to the CPAP mask device, high flow nasal insufflation is a possible alternative treatment. We aim to randomise these patients into 4 groups, receiving conventional CPAP face mask or high flow nasal cannula at 3 flow rates, and study them with respect to incidence and number of documented desaturations. In addition, patient satisfaction, compliance to device and any adverse events will be monitored.

Registry
clinicaltrials.gov
Start Date
September 13, 2018
End Date
July 31, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tsai Fung Chen

Consultant, Department of Anaesthesia & Surgical Intensive Care

Changi General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients aged 21-85 years old presenting for elective surgery.
  • Suspected/possible OSA patients who are enrolled in the "fast-track OSA protocol" in the pre-assessment clinic
  • Patients started on CPAP therapy at least one day pre-operatively
  • Patients who are admitted to the High Dependency unit for postoperative monitoring.

Exclusion Criteria

  • Patients with nasal obstruction.
  • Patients undergoing nasal or facial surgery, or surgery to treat OSA (eg. uvulopalatopharyngoplasty).
  • Patients who already require a higher oxygen concentration (FiO2 \> 0.21) preoperatively.

Outcomes

Primary Outcomes

Number of participants with documented desaturations (defined as >4% drop from baseline)

Time Frame: 10 hours (between 10pm on first postoperative night and 8am the following day)

Number of documented desaturations (defined as \>4% below baseline) in OSA patients who receive CPAP face mask or high flow nasal insufflation on the first postoperative night

Secondary Outcomes

  • Number of participants with any adverse effects of the applied therapy in the immediate postoperative setting.(10 hours (between 10pm on first postoperative night and 8am the following day))
  • Number of participants who need for supplemental oxygen and/ or the need for other interventions to reverse the desaturations.(10 hours (between 10pm on first postoperative night and 8am the following day))
  • Patients' perceptions of the comfort of each device on scale of 0 to 100(10 hours (between 10pm on first postoperative night and 8am the following day))

Study Sites (1)

Loading locations...

Similar Trials